Evidence map›Paper›PMID 41469566›Full record

ArticleBMC cardiovascular disorders2025

Very high power short duration as re-ablation strategy for recurrent atrial fibrillation.

Jana Ackmann, Jonas Wörmann, Jakob Lüker, Jan-Hendrik Schipper, Jan-Hendrik van den Bruck, Cornelia Scheurlen, Sebastian Dittrich, Friederike Pavel, Theodoros Maximidou, Daniel Steven and 1 more

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jana AckmannDepartment of Electrophysiology, Heart Center, University of Cologne, Kerpener Str. 62, Cologne, 50937, Germany. jana.ackmann@uk-koeln.de.
Jonas WörmannDepartment of Electrophysiology, Heart Center, University of Cologne, Kerpener Str. 62, Cologne, 50937, Germany.
Jakob LükerDepartment of Electrophysiology, Heart Center, University of Cologne, Kerpener Str. 62, Cologne, 50937, Germany.
Jan-Hendrik SchipperDepartment of Electrophysiology, Heart Center, University of Cologne, Kerpener Str. 62, Cologne, 50937, Germany.
Jan-Hendrik van den BruckDepartment of Electrophysiology, Heart Center, University of Cologne, Kerpener Str. 62, Cologne, 50937, Germany.
Cornelia ScheurlenDepartment of Electrophysiology, Heart Center, University of Cologne, Kerpener Str. 62, Cologne, 50937, Germany.
Sebastian DittrichDepartment of Electrophysiology, Heart Center, University of Cologne, Kerpener Str. 62, Cologne, 50937, Germany.
Friederike PavelDepartment of Electrophysiology, Heart Center, University of Cologne, Kerpener Str. 62, Cologne, 50937, Germany.
Theodoros MaximidouDepartment of Electrophysiology, Heart Center, University of Cologne, Kerpener Str. 62, Cologne, 50937, Germany.
Daniel StevenDepartment of Electrophysiology, Heart Center, University of Cologne, Kerpener Str. 62, Cologne, 50937, Germany.
Arian SultanAsklepios Hospital St. Georg, Heart Center, Lohmühlenstrasse 5, Hamburg, 20099, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAfter initially successful pulmonary vein isolation (PVI), some patients experience recurrence of AF requiring repeat catheter ablation. Radiofrequency ablation (RFA) is then mostly performed with low power long duration settings (LPLD), while very high power short duration (vHPSD) may be a valuable alternative. This study aimed to compare procedural parameters, outcomes and complication rates of both approaches.

methodsAll consecutive repeat procedures for recurrent AF between 12/2019 and 03/2023 were retrospectively analyzed at our center. Only patients with at least one prior ablation were included. RFA was performed using LPLD (≤ 40 W) or vHPSD (≥ 70 W, 7 s). Ablation strategies were at the operators’ discretion.

resultsA total of 340 procedures were included (LPLD: 292; vHPSD: 48). Re-PVI was necessary in the majority of cases (LPLD: 67.8%; vHPSD: 70.8%; p = 0.7). Additional ablation lines were performed in 59.9% (LPLD) and 75.0% (vHPSD; p = 0.1). In the vHPSD group more patients underwent substrate modification (CFAE ablation/scar encirclement; LPLD: 27.7%; vHPSD: 45.8%; p = 0.017). Despite this, RF delivery time was shorter with vHPSD (LPLD: 2024 ± 1014 s; vHPSD: 1591 ± 936 s; p = 0.006), while total procedure duration (LPLD: 142.8 ± 45.8 min; vHPSD: 139.2 ± 48.2 min; p = 0.7) and complication rates (LPLD: 5.1%; vHPSD: 8.3%; p = 0.3) were similar. After a median follow-up of 361 days, arrhythmia-free survival was comparable between groups (LPLD: 65.7%; vHPSD: 68.8%; p = 0.8).

conclusionvHPSD is an efficient alternative to conventional RFA in repeat procedures for recurrent AF, even in complex cases requiring extended lesion sets.

Indexed as

Atrial FibrillationCatheter AblationPulmonary VeinsAction PotentialsAgedFemaleHeart RateHumansMaleMiddle AgedRecurrenceReoperationRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsAtrial fibrillationCatheter ablationHigh-Power Short-Duration (HPSD)PVIRadiofrequency ablationRe-ablation

Identifiers

PMID41469566
PMCPMC12837070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.